医院提供者对MOUD启动和在住院患者出院后继续治疗的观点
Riley Shearer1, Honora Englander2, Hildi Hagedorn3
1University of Minnesota School of Public Health, Minneapolis, MN, USA.
Journal of general internal medicine
|November 25, 2024
概括
由于社区治疗障碍,医院提供者面临着启动用于阿片类药物使用障碍 (MOUD) 药物治疗的挑战. 解决这些差距对于有效的住院MOUD计划和患者的护理连续性至关重要.
科学领域:
- 成 药物 药物 药物 药物
- 医疗保健服务研究 医疗服务研究
- 实施科学 实施科学
背景情况:
- 在住院患者中,阿片类药物使用障碍 (OUD) 很普遍,这为治疗启动提供了关键机会.
- 尽管如此,许多患者在住院期间没有接受阿片类药物使用障碍 (MOUD) 的药物治疗.
- 在出院后继续MOUD存在障碍,影响治疗的有效性.
研究的目的:
- 探索医院提供者对启动和继续MOUD的障碍的观点.
- 为支持医院MOUD和社区过渡的战略和政策提供信息.
主要方法:
- 与12家社区医院的57家医院提供者进行了半结构面试.
- 主题分析侧重于将患者转移到门诊MOUD治疗的挑战.
- 这项研究是更大的实施研究的一部分 (NCT#04921787).
主要成果:
- 提供者确定了门诊MOUD延续的结构性障碍:有限的布普伦诺芬处方者,分散的成治疗系统和长时间的等待时间.
- 这些障碍造成了一种无用的感觉,不鼓励住院患者启动MOUD.
- 提供者建议发展医院-门诊伙伴关系和接触服务.
结论:
- 社区成护理的不足和难以获得,阻碍了医院提供者开出MOUD.
- 需要有效的程序和政策策略来改善MOUD的住院到门诊的过渡.
- 扩大医院阿片类药物治疗需要强有力的支持社区护理整合.
相关概念视频
Discharge Summary Forms
744
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
744
Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
Opioid Analgesics: Synthetic and Semisynthetic Opioids
225
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
225
Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
Analgesia and Pain Management
513
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
513
Drug Dependence
979
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
979


